Table 4 Availability of anti-malarial drugs in Sierra Leone (127 outlets surveyed), by public, charitable and private sectors
From: Anti-malarial market and policy surveys in sub-Saharan Africa
| Â | Number of anti-malarials in outlets surveyed (n=340) | Number of anti-malarials in government/public sector (n=141) | Number of anti-malarials in mission/NGO (n=67) | Number of anti-malarials in the private sector(n=132) |
|---|---|---|---|---|
AM+LUM | 3 (0.9%) | 0 | 1 (1.5%) | 2 (1.5%) |
AQ | 8 (2.4%) | 1 (0.7%) | 1 (1.5%) | 6 (4.5%) |
AR | 13 (3.8%) | 3 (2.1%) | 4 (6.0%) | 6 (4.5%) |
AS | 15 (4.4%) | 2 (1.4%) | 3 (4.5%) | 10 (7.6%) |
AS+AQ | 100 (29.4%) | 55 (39.0%) | 20 (29.9%) | 25 (18.9%) |
AS+MQ | 1 (0.3%) | 0 | 0 | 1 (0.8%) |
AS+SP | 6 (1.8%) | 0 | 1 (1.5%) | 5 (3.8%) |
Chloroquine | 35 (10.3%) | 0 | 4 (6.0%) | 31 (23.5%) |
Halofantrine | 3 (0.9%) | 0 | 0 | 3 (2.3%) |
MQ | 3 (0.9%) | 0 | 1 (1.5%) | 2 (1.5%) |
Proguanil | 1 (0.3%) | 0 | 0 | 1 (0.8%) |
Pyrimethamine | 1 (0.3%) | 0 | 0 | 1 (0.8%) |
Quinine | 67 (19.7%) | 36 (25.5%) | 16 (23.9%) | 15 (11.4%) |
SP | 84 (24.7%) | 44 (31.2%) | 16 (23.9%) | 24 (18.2%) |